Skip to main content

Table 2 Patients Characteristics and prevalence of circulating tumor cells

From: Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer

Characteristics

No.

CTCs (CTC Units/5 ml)

Epithelial CTCs

Mixed CTCs

Mesenchymal CTCs

Total CTCs

M

P25-P75

P

M

P25-P75

P

M

P25-P75

P

M

P25-P75

P

Benign lung diseases

38

0

0-0

<  0.01

0

0-0

<  0.01

0

0-0

0.013

0

0-0

< 0.01

NSCLC

98

1

0-2

 

1

0-3

 

0

0-1

 

3

1-6

 

Pathological type

   

0.845

  

0.528

  

0.904

  

0.579

 AC

60

1

0-2.75

 

1.5

0-3

 

0

0-1

 

3

1-6

 

 SC

33

1

0-2

 

1

0-2

 

2

0-0.5

 

2

1-5

 

 Others

5

1

0.5-3

 

2

0-3

 

1

0.5-1

 

2

1-7

 

TNM stage

   

0.850

  

0.954

  

0.505

  

0.926

 I

48

1

0-2

 

1

0-3

 

0

0-1

 

3

1-6

 

 II

13

1

0.5-3

 

1

0-4

 

0

0-1

 

3

1-11

 

 III

29

1

0-2.5

 

1

0-3

 

0

0-0.5

 

3

1-6

 

 IV

8

1.5

0-4.5

 

1

0.25-5

 

0.5

0-1.75

 

3

0.25-12.75

 

Age

             

  ≤ 60y

74

1

0-2

0.446

1

0-3

0.470

0

0-1

0.353

3

1-6

1

  > 60y

24

1

0-2

 

0

0-3.75

 

0

0-0

 

2.5

0-6

 
  1. Abbreviations: NSCLC non-small cell lung cancer, AC Adenocarcinoma, SC Squamous carcinoma, CTCs circulating tumor cells, M median, P25-P75 inter-quartile range
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us